| Host: |
Rabbit |
| Applications: |
IHC/WB |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-GABRA1 (390-450 aa) is suitable for use in Immunohistochemistry and Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Lyophilised |
| Purification: |
IgG purified |
| Dilution Range: |
IHC, WB. A dilution of 1:2000 to 1:3000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications. |
| Storage Instruction: |
Maintain the lyophilised/reconstituted antibodies frozen at-20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, Glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
| Gene Symbol: |
GABRA1 |
| Gene ID: |
2554 |
| Uniprot ID: |
GBRA1_HUMAN |
| Immunogen Region: |
390-450 aa |
| Specificity: |
Specific for GABA (A) receptor subunit alpha-1. |
| Immunogen: |
A synthetic peptide from aa region 390-450 of human GABRA1 conjugated to blue carrier protein was used as the antigen. The peptide is homologous in rat and mouse. |
| Protein Name | Gamma-Aminobutyric Acid Receptor Subunit Alpha-1Gaba(A Receptor Subunit Alpha-1Gabaar Subunit Alpha-1 |
| Database Links | Reactome: R-HSA-1236394Reactome: R-HSA-977443 |
| Cellular Localisation | Postsynaptic Cell MembraneMulti-Pass Membrane ProteinCell MembraneCytoplasmic Vesicle MembraneMainly Located In Gabaergic Synapses In Granule CellsAnd Also In The Extrasynaptic Membrane At A Lower Concentration |
| Alternative Antibody Names | Anti-Gamma-Aminobutyric Acid Receptor Subunit Alpha-1 antibodyAnti-Gaba(A Receptor Subunit Alpha-1 antibodyAnti-Gabaar Subunit Alpha-1 antibodyAnti-GABRA1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
